MB
Mobius Biotechnology utilizes a clinically validated platform integrating AI and wet lab capabilities to identify and develop novel anticancer drugs. This approach focuses on interrogating disease mechanisms directly in live human tissue samples, moving beyond limitations of traditional animal models. The company aims to deliver oncology medicines rooted in human biology designed for clinical success.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Mobius Biotechnology utilizes a clinically validated platform integrating AI and wet lab capabilities to identify and develop novel anticancer drugs. This approach focuses on interrogating disease mechanisms directly in live human tissue samples, moving beyond limitations of traditional animal models. The company aims to deliver oncology medicines rooted in human biology designed for clinical success.